• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工智能在评估年龄相关性黄斑变性进展中的应用

Artificial intelligence in assessing progression of age-related macular degeneration.

作者信息

Frank-Publig Sophie, Birner Klaudia, Riedl Sophie, Reiter Gregor S, Schmidt-Erfurth Ursula

机构信息

Laboratory for Ophthalmic Image Analysis, Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.

出版信息

Eye (Lond). 2025 Feb;39(2):262-273. doi: 10.1038/s41433-024-03460-z. Epub 2024 Nov 18.

DOI:10.1038/s41433-024-03460-z
PMID:39558093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11751489/
Abstract

The human population is steadily growing with increased life expectancy, impacting the prevalence of age-dependent diseases, including age-related macular degeneration (AMD). Health care systems are confronted with an increasing burden with rising patient numbers accompanied by ongoing developments of therapeutic approaches. Concurrent advances in imaging modalities provide eye care professionals with a large amount of data for each patient. Furthermore, with continuous progress in therapeutics, there is an unmet need for reliable structural and functional biomarkers in clinical trials and practice to optimize personalized patient care and evaluate individual responses to treatment. A fast and objective solution is Artificial intelligence (AI), which has revolutionized assessment of AMD in all disease stages. Reliable and validated AI-algorithms can aid to overcome the growing number of patients, visits and necessary treatments as well as maximize the benefits of multimodal imaging in clinical trials. Therefore, there are ongoing efforts to develop and validate automated algorithms to unlock more information from datasets allowing automated assessment of disease activity and disease progression. This review aims to present selected AI algorithms, their development, applications and challenges regarding assessment and prediction of AMD progression.

摘要

随着预期寿命的增加,人口在稳步增长,这影响了包括年龄相关性黄斑变性(AMD)在内的与年龄相关疾病的患病率。医疗保健系统面临着日益增加的负担,患者数量不断上升,同时治疗方法也在不断发展。成像技术的同步进步为眼科护理专业人员提供了每个患者的大量数据。此外,随着治疗方法的不断进步,在临床试验和实践中,对于可靠的结构和功能生物标志物存在未满足的需求,以优化个性化患者护理并评估个体对治疗的反应。一个快速且客观的解决方案是人工智能(AI),它彻底改变了对AMD所有疾病阶段的评估。可靠且经过验证的AI算法有助于克服患者数量、就诊次数和必要治疗不断增加的问题,并在临床试验中最大化多模态成像的益处。因此,人们正在不断努力开发和验证自动化算法,以从数据集中挖掘更多信息,实现对疾病活动和疾病进展的自动化评估。本综述旨在介绍有关AMD进展评估和预测的选定AI算法、其开发、应用及挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7e9/11751489/7b6bb541ac13/41433_2024_3460_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7e9/11751489/2d4f2675f86c/41433_2024_3460_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7e9/11751489/6b7a83e64c7f/41433_2024_3460_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7e9/11751489/f3c24b9f6f58/41433_2024_3460_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7e9/11751489/7b6bb541ac13/41433_2024_3460_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7e9/11751489/2d4f2675f86c/41433_2024_3460_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7e9/11751489/6b7a83e64c7f/41433_2024_3460_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7e9/11751489/f3c24b9f6f58/41433_2024_3460_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7e9/11751489/7b6bb541ac13/41433_2024_3460_Fig4_HTML.jpg

相似文献

1
Artificial intelligence in assessing progression of age-related macular degeneration.人工智能在评估年龄相关性黄斑变性进展中的应用
Eye (Lond). 2025 Feb;39(2):262-273. doi: 10.1038/s41433-024-03460-z. Epub 2024 Nov 18.
2
Artificial intelligence for diagnosing exudative age-related macular degeneration.人工智能在渗出性年龄相关性黄斑变性诊断中的应用。
Cochrane Database Syst Rev. 2024 Oct 17;10(10):CD015522. doi: 10.1002/14651858.CD015522.pub2.
3
Imaging and artificial intelligence for progression of age-related macular degeneration.与年龄相关的黄斑变性的影像学和人工智能。
Exp Biol Med (Maywood). 2021 Oct;246(20):2159-2169. doi: 10.1177/15353702211031547. Epub 2021 Aug 18.
4
Characterization of Drusen and Hyperreflective Foci as Biomarkers for Disease Progression in Age-Related Macular Degeneration Using Artificial Intelligence in Optical Coherence Tomography.利用人工智能在光学相干断层扫描中对年龄相关性黄斑变性的特征进行分析,以评估其作为疾病进展的生物标志物。
JAMA Ophthalmol. 2020 Jul 1;138(7):740-747. doi: 10.1001/jamaophthalmol.2020.1376.
5
[Use of artificial intelligence for recognition of biomarkers in intermediate age-related macular degeneration].[人工智能在中间型年龄相关性黄斑变性生物标志物识别中的应用]
Ophthalmologie. 2024 Aug;121(8):609-615. doi: 10.1007/s00347-024-02078-6. Epub 2024 Jul 31.
6
A Novel Management Challenge in Age-Related Macular Degeneration: Artificial Intelligence and Expert Prediction of Geographic Atrophy.年龄相关性黄斑变性中的一个新管理挑战:地理萎缩的人工智能与专家预测
Ophthalmol Retina. 2025 May;9(5):421-430. doi: 10.1016/j.oret.2024.10.029. Epub 2024 Nov 9.
7
From Data to Deployment: The Collaborative Community on Ophthalmic Imaging Roadmap for Artificial Intelligence in Age-Related Macular Degeneration.从数据到部署:眼科成像人工智能相关的年龄相关性黄斑变性协作社区路线图。
Ophthalmology. 2022 May;129(5):e43-e59. doi: 10.1016/j.ophtha.2022.01.002. Epub 2022 Jan 10.
8
Evaluation of an Artificial Intelligence-Based Detector of Sub- and Intraretinal Fluid on a Large Set of Optical Coherence Tomography Volumes in Age-Related Macular Degeneration and Diabetic Macular Edema.基于人工智能的视网膜下和视网膜内液检测在大量年龄相关性黄斑变性和糖尿病性黄斑水肿光学相干断层扫描体积上的评估。
Ophthalmologica. 2022;245(6):516-527. doi: 10.1159/000527345. Epub 2022 Oct 10.
9
Detection of macular atrophy in age-related macular degeneration aided by artificial intelligence.人工智能辅助检测年龄相关性黄斑变性的黄斑萎缩。
Expert Rev Mol Diagn. 2023 Jun;23(6):485-494. doi: 10.1080/14737159.2023.2208751. Epub 2023 May 5.
10
Artificial intelligence-based decision-making for age-related macular degeneration.基于人工智能的年龄相关性黄斑变性决策。
Theranostics. 2019 Jan 1;9(1):232-245. doi: 10.7150/thno.28447. eCollection 2019.

引用本文的文献

1
Integrating Artificial Intelligence and Precision Therapeutics for Advancing the Diagnosis and Treatment of Age-Related Macular Degeneration.整合人工智能与精准治疗以推进年龄相关性黄斑变性的诊断与治疗
Bioengineering (Basel). 2025 May 20;12(5):548. doi: 10.3390/bioengineering12050548.
2
Imaging of Geographic Atrophy: A Practical Approach.地图样萎缩的影像学检查:实用方法
Ophthalmol Ther. 2025 May 5. doi: 10.1007/s40123-025-01158-3.
3
Sustaining Ophthalmic Practices for the Future: A High-Value Care Approach to Environmental Responsibility.

本文引用的文献

1
Sequence of Morphological Changes Preceding Atrophy in Intermediate AMD Using Deep Learning.深度学习在 AMD 中期萎缩前的形态变化序列。
Invest Ophthalmol Vis Sci. 2024 Jul 1;65(8):30. doi: 10.1167/iovs.65.8.30.
2
Imaging geographic atrophy: integrating structure and function to better understand the effects of new treatments.影像学检查地图样萎缩:整合结构与功能,更好地了解新疗法的效果。
Br J Ophthalmol. 2024 May 21;108(6):773-778. doi: 10.1136/bjo-2023-324246.
3
Choroidal signal hypertransmission on optical coherence tomography imaging: Association with development of geographic atrophy in age-related macular degeneration.
为未来维持眼科医疗业务:一种对环境责任的高价值医疗护理方法。
Ophthalmol Ther. 2025 Jun;14(6):1199-1218. doi: 10.1007/s40123-025-01146-7. Epub 2025 Apr 28.
4
Rethinking Clinical Trials in Age-Related Macular Degeneration: How AI-Based OCT Analysis Can Support Successful Outcomes.重新思考年龄相关性黄斑变性的临床试验:基于人工智能的光学相干断层扫描分析如何助力取得成功结果。
Pharmaceuticals (Basel). 2025 Feb 20;18(3):284. doi: 10.3390/ph18030284.
5
Age-related macular degeneration in 2025- opportunities and challenges.2025年的年龄相关性黄斑变性——机遇与挑战
Eye (Lond). 2025 May;39(7):1231-1232. doi: 10.1038/s41433-025-03710-8. Epub 2025 Feb 26.
脉络膜信号超传递在光学相干断层扫描成像中的表现:与年龄相关性黄斑变性中地图样萎缩的发展相关。
Clin Exp Ophthalmol. 2024 May-Jun;52(4):431-439. doi: 10.1111/ceo.14356. Epub 2024 Jan 29.
4
Deep-learning-based automated measurement of outer retinal layer thickness for use in the assessment of age-related macular degeneration, applicable to both swept-source and spectral-domain OCT imaging.基于深度学习的视网膜外层厚度自动测量,用于年龄相关性黄斑变性评估,适用于扫频源和谱域光学相干断层扫描成像。
Biomed Opt Express. 2023 Dec 22;15(1):413-427. doi: 10.1364/BOE.512359. eCollection 2024 Jan 1.
5
Long-term effect of fluid volumes during the maintenance phase in neovascular age-related macular degeneration: results from Fight Retinal Blindness!新生血管性年龄相关性黄斑变性维持期液体摄入量的长期影响:来自 Fight Retinal Blindness 的结果!
Can J Ophthalmol. 2024 Oct;59(5):350-357. doi: 10.1016/j.jcjo.2023.10.017. Epub 2023 Nov 18.
6
Automated deep learning-based AMD detection and staging in real-world OCT datasets (PINNACLE study report 5).基于自动化深度学习的真实世界 OCT 数据集 AMD 检测和分期(PINNACLE 研究报告 5)。
Sci Rep. 2023 Nov 9;13(1):19545. doi: 10.1038/s41598-023-46626-7.
7
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.培格司他单抗治疗与年龄相关的黄斑变性(OAKS 和 DERBY)相关的地图状萎缩:两项多中心、随机、双盲、假对照、3 期临床试验。
Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9.
8
A Deep-Learning Algorithm to Predict Short-Term Progression to Geographic Atrophy on Spectral-Domain Optical Coherence Tomography.一种基于深度学习算法预测光谱域光学相干断层扫描下的地理萎缩短期进展。
JAMA Ophthalmol. 2023 Nov 1;141(11):1052-1061. doi: 10.1001/jamaophthalmol.2023.4659.
9
Approved AI-based fluid monitoring to identify morphological and functional treatment outcomes in neovascular age-related macular degeneration in real-world routine.批准基于人工智能的液体监测,以在真实世界的常规中识别新生血管性年龄相关性黄斑变性的形态和功能治疗结果。
Br J Ophthalmol. 2024 Jun 20;108(7):971-977. doi: 10.1136/bjo-2022-323014.
10
A foundation model for generalizable disease detection from retinal images.基于视网膜图像的通用疾病检测的基础模型。
Nature. 2023 Oct;622(7981):156-163. doi: 10.1038/s41586-023-06555-x. Epub 2023 Sep 13.